phenox launches pToWin Study to assess efficacy of pCONus Bifurcation Aneurysm Implant
phenox summarized the excellent results of the ARTESp study (Acute Recanalization of Thrombo Embolic Stroke with pREset) in a two-page flyer that you can find attached - as well as in company website. ARTESp is a prospective, multicenter, single-arm Post Market Clinical Follow-up study in which effectiveness, safety and long-term success of the pREset Thrombectomy Device was analyzed in acute occlusions of major cerebral arteries of both anterior and posterior circulation. The corresponding publication is in progress and the results will be presented at various upcoming congresses.
After the completion of the ARTESp Study (Acute Recanalization of Thrombo Embolic Stroke with pREset) phenox GmbH has now launched the clinical investigation of yet another innovative medical device for endovascular stroke treatment. Coordinated by Neuroradiologist Prof. Dr. Alessandra Biondi, CHU Besançon, France, internationally renowned centers in Europe and South America will assess the pCONus® implant in their daily clinic routine. “pCONus provides the Interventional Neuroradiologist with an important tool to treat complex wide neck bifurcation aneurysms and this study will help the interventional community to better understand it’s benefits,” says Prof. Biondi. A Core Lab will assess the aneurysm occlusion after the treatment and again at 6 and 12 months post treatment. The study will enroll 100 patients over the next two years and the results are to be published in a peer-reviewed scientific journal after completion.
For more information please contact: